Becker's Healthcare March 11, 2024
Andrew Cass

R1 RCM has formed a special committee of independent directors to evaluate “strategic alternatives” in the wake of two major shareholders mulling an offer to take the company private.

Private equity firm New Mountain Capital and TCP-ASC — an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance — are considering a potential cash offer of $13.75 per share for all R1’s outstanding stock. New Mountain owns 32.4% of R1 and TowerBrook owns 29.6%.

In a March 11 news release, R1 said it “welcomes open, constructive communications with all stockholders and encourages input that advances our shared goal of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Exchange Wrapup: Rev Cycle Tech ROI is Serious Business
Accelerating Demand for Specialized RCM Solutions in Outpatient and Ancillary Services Set to Surge in 2025, Reports Black Book Research
Unlocking Hidden Revenue: Transforming RCM Challenges into Financial Wins
Protecting revenue integrity in the age of denials — 4 takeaways
8 Tips for Effective Revenue Cycle Technology Management

Share This Article